The biology of Mur ligases as an antibacterial target

Molecular Microbiology

Volumn 94, Issue 2, 2014, Pages 242-253

  Kouidmi, Imène ^a   Levesque, Roger C ^b   Paradis Bleau, Catherine ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMIDE; ANTIBIOTIC AGENT; BENZENE 1,3 DICARBOXYLIC ACID 2,5 DIMETHYLPYRROLE DERIVATIVE; ENZYME INHIBITOR; MURC LIGASE; MURC LIGASE INHIBITOR; MURD LIGASE; MURD LIGASE INHIBITOR; MURE LIGASE; MURE LIGASE INHIBITOR; MURF LIGASE; MURF LIGASE INHIBITOR; PEPTIDOGLYCAN; POLYPEPTIDE ANTIBIOTIC AGENT; PYRROLE DERIVATIVE; SULFONAMIDE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; LIGASE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BINDING AFFINITY; BINDING KINETICS; BINDING SITE; CATALYSIS; CONFORMATIONAL TRANSITION; DIMERIZATION; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME INHIBITION; HUMAN; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; STRUCTURE ACTIVITY RELATION; BACTERIUM; CELL WALL; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM;

BACTERIA; CELL WALL; LIGASES; MODELS, MOLECULAR; PEPTIDOGLYCAN;

EID: 84916931551     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/mmi.12758     Document Type: Review

References (89)

1. Anderson, M.S., Eveland, S.S., Onishi, H.R., and Pompliano, D.L. (1996) Kinetic mechanism of the Escherichia coli UDPMurNAc-tripeptide D-alanyl-D-alanine-adding enzyme: use of a glutathione S-transferase fusion. Biochemistry 35: 16264-16269.
2. Anishetty, S., Pulimi, M., and Pennathur, G. (2005) Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis. Comput Biol Chem 29: 368-378.
3. Anuradha, C.M., Mulakayala, C., Babajan, B., Naveen, M., Rajasekhar, C., and Kumar, C.S. (2010) Probing ligand binding modes of Mycobacterium tuberculosis MurC ligase by molecular modeling, dynamics simulation and docking. J Mol Model 16: 77-85.
4. Baum, E.Z., Crespo-Carbone, S.M., Klinger, A., Foleno, B.D., Turchi, I., Macielag, M., and Bush, K. (2007) A MurF inhibitor that disrupts cell wall biosynthesis in Escherichia coli. Antimicrob Agents Chemother 51: 4420-4426.
5. Baum, E.Z., Crespo-Carbone, S.M., Foleno, B.D., Simon, L.D., Guillemont, J., Macielag, M., and Bush, K. (2009) MurF inhibitors with antibacterial activity: effect on muropeptide levels. Antimicrob Agents Chemother 53: 3240-3247.
6. Bertrand, J.A., Auger, G., Fanchon, E., Martin, L., Blanot, D., van Heijenoort, J., and Dideberg, O. (1997) Crystal structure of UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase from Escherichia coli. EMBO J 16: 3416-3425.
7. Bertrand, J.A., Auger, G., Martin, L., Fanchon, E., Blanot, D., Le Beller, D., etal. (1999) Determination of the MurD mechanism through crystallographic analysis of enzyme complexes. J Mol Biol 289: 579-590.
8. Bertrand, J.A., Fanchon, E., Martin, L., Chantalat, L., Auger, G., Blanot, D., etal. (2000) 'Open' structures of MurD: domain movements and structural similarities with folylpolyglutamate synthetase. J Mol Biol 301: 1257-1266.
9. Boniface, A., Bouhss, A., Mengin-Lecreulx, D., and Blanot, D. (2006) The MurE synthetase from Thermotoga maritima is endowed with an unusual D-lysine-adding activity. J Biol Chem 281: 15680-15686.
10. Bouhss, A., Mengin-Lecreulx, D., Blanot, D., van Heijenoort, J., and Parquet, C. (1997) Invariant amino acids in the Mur peptide synthetases of bacterial peptidoglycan synthesis and their modification by site-directed mutagenesis in the UDP-MurNAc:L-alanine ligase from Escherichia coli. Biochemistry 36: 11556-11563.
11. Bouhss, A., Dementin, S., van Heijenoort, J., Parquet, C., and Blanot, D. (2002) MurC and MurD synthetases of peptidoglycan biosynthesis: borohydride trapping of acyl-phosphate intermediates. Methods Enzymol 354: 189-196.
12. Brown, E.D., and Wright, G.D. (2005) New targets and screening approaches in antimicrobial drug discovery. Chem Rev 105: 759-774.
13. Bugg, T.D., and Walsh, C.T. (1992) Intracellular steps of bacterial cell wall peptidoglycan biosynthesis: enzymology, antibiotics, and antibiotic resistance. Nat Prod Rep 9: 199-215.
14. Burghout, P., Quintero, B., Bos, L., Beilharz, K., Veening, J.W., de Jonge, M.I., etal. (2013) A single amino acid substitution in the MurF UDP-MurNAc-pentapeptide synthetase renders Streptococcus pneumoniae dependent on CO2 and temperature. Mol Microbiol 89: 494-506.
15. Cava, F., de Pedro, M.A., Lam, H., Davis, B.M., and Waldor, M.K. (2011) Distinct pathways for modification of the bacterial cell wall by non-canonical D-amino acids. EMBO J 30: 3442-3453.
16. Consaul, S.A., Wright, L.F., Mahapatra, S., Crick, D.C., and Pavelka, M.S., Jr (2005) An unusual mutation results in the replacement of diaminopimelate with lanthionine in the peptidoglycan of a mutant strain of Mycobacterium smegmatis. J Bacteriol 187: 1612-1620.
17. Daniel, R.A., and Errington, J. (2003) Control of cell morphogenesis in bacteria. Cell 113: 767-776.
18. Davies, J., and Davies, D. (2010) Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74: 417-433.
19. Deva, T., Baker, E.N., Squire, C.J., and Smith, C.A. (2006) Structure of Escherichia coli UDP-N-acetylmuramoyl:L-alanine ligase (MurC). Acta Crystallogr D Biol Crystallogr 62: 1466-1474.
20. East, S.P., and Silver, L.L. (2013) Multitarget ligands in antibacterial research: progress and opportunities. Expert Opin Drug Discov 8: 143-156.
21. El Zoeiby, A., Sanschagrin, F., and Levesque, R.C. (2003) Structure and function of the Mur enzymes: development of novel inhibitors. Mol Microbiol 47: 1-12.
22. Emanuele, J.J., Jr, Jin, H., Yanchunas, J., Jr, and Villafranca, J.J. (1997) Evaluation of the kinetic mechanism of Escherichia coli uridine diphosphate-N-acetylmuramate:L-alanine ligase. Biochemistry 36: 7264-7271.
23. Eveland, S.S., Pompliano, D.L., and Anderson, M.S. (1997) Conditionally lethal Escherichia coli murein mutants contain point defects that map to regions conserved among murein and folyl poly-gamma-glutamate ligases: identification of a ligase superfamily. Biochemistry 36: 6223-6229.
24. Falk, S.P., and Weisblum, B. (2013) Phosphorylation of the Streptococcus pneumoniae cell wall biosynthesis enzyme MurC by a eukaryotic-like Ser/Thr kinase. FEMS Microbiol Lett 340: 19-23.
25. Fauci, A.S., and Morens, D.M. (2012) The perpetual challenge of infectious diseases. N Engl J Med 366: 454-461.
26. Favini-Stabile, S., Contreras-Martel, C., Thielens, N., and Dessen, A. (2013) MreB and MurG as scaffolds for the cytoplasmic steps of peptidoglycan biosynthesis. Environ Microbiol 15: 3218-3228.
27. Fiuza, M., Canova, M.J., Patin, D., Letek, M., Zanella-Cleon, I., Becchi, M., etal. (2008) The MurC ligase essential for peptidoglycan biosynthesis is regulated by the serine/threonine protein kinase PknA in Corynebacterium glutamicum. J Biol Chem 283: 36553-36563.
28. Gaballah, A., Kloeckner, A., Otten, C., Sahl, H.G., and Henrichfreise, B. (2011) Functional analysis of the cytoskeleton protein MreB from Chlamydophila pneumoniae. PLoS ONE 6: e25129.
29. Gordon, E., Flouret, B., Chantalat, L., van Heijenoort, J., Mengin-Lecreulx, D., and Dideberg, O. (2001) Crystal structure of UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: meso-diaminopimelate ligase from Escherichia coli. J Biol Chem 276: 10999-11006.
30. Green, D.W. (2002) The bacterial cell wall as a source of antibacterial targets. Expert Opin Ther Targets 6: 1-19.
31. Hameed, P.S., Manjrekar, P., Chinnapattu, M., Humnabadkar, V., Shanbhag, G., Kedari, C., etal. (2014) Pyrazolopyrimidines establish MurC as a vulnerable target in Pseudomonas aeruginosa and Escherichia coli. ACS Chem Biol [Epub ahead of print].
32. van Heijenoort, J. (2001) Recent advances in the formation of the bacterial peptidoglycan monomer unit. Nat Prod Rep 18: 503-519.
33. Hesse, L., Bostock, J., Dementin, S., Blanot, D., Mengin-Lecreulx, D., and Chopra, I. (2003) Functional and biochemical analysis of Chlamydia trachomatis MurC, an enzyme displaying UDP-N-acetylmuramate:amino acid ligase activity. J Bacteriol 185: 6507-6512.
34. Holtje, J.V. (1998) Growth of the stress-bearing and shape-maintaining murein sacculus of Escherichia coli. Microbiol Mol Biol Rev 62: 181-203.
35. Horcajo, P., de Pedro, M.A., and Cava, F. (2012) Peptidoglycan plasticity in bacteria: stress-induced peptidoglycan editing by noncanonical D-amino acids. Microb Drug Resist 18: 306-313.
36. Hrast, M., Turk, S., Sosic, I., Knez, D., Randall, C.P., Barreteau, H., etal. (2013) Structure-activity relationships of new cyanothiophene inhibitors of the essential peptidoglycan biosynthesis enzyme MurF. Eur J Med Chem 66: 32-45.
37. Hrast, M., Sosic, I., Sink, R., and Gobec, S. (2014) Inhibitors of the peptidoglycan biosynthesis enzymes MurA-F. Bioorg Chem 55: 2-15.
38. Humljan, J., Kotnik, M., Contreras-Martel, C., Blanot, D., Urleb, U., Dessen, A., etal. (2008) Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme. J Med Chem 51: 7486-7494.
39. Jin, H., Emanuele, J.J., Jr, Fairman, R., Robertson, J.G., Hail, M.E., Ho, H.T., etal. (1996) Structural studies of Escherichia coli UDP-N-acetylmuramate:L-alanine ligase. Biochemistry 35: 1423-1431.
40. Katz, A.H., and Caufield, C.E. (2003) Structure-based design approaches to cell wall biosynthesis inhibitors. Curr Pharm Des 9: 857-866.
41. Kotnik, M., Anderluh, P.S., and Prezelj, A. (2007a) Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis. Curr Pharm Des 13: 2283-2309.
42. Kotnik, M., Humljan, J., Contreras-Martel, C., Oblak, M., Kristan, K., Herve, M., etal. (2007b) Structural and functional characterization of enantiomeric glutamic acid derivatives as potential transition state analogue inhibitors of MurD ligase. J Mol Biol 370: 107-115.
43. Kurokawa, K., Nishida, S., Ishibashi, M., Mizumura, H., Ueno, K., Yutsudo, T., etal. (2008) Staphylococcus aureus MurC participates in L-alanine recognition via histidine 343, a conserved motif in the shallow hydrophobic pocket. J Biochem (Tokyo) 143: 417-424.
44. Lam, H., Oh, D.C., Cava, F., Takacs, C.N., Clardy, J., de Pedro, M.A., and Waldor, M.K. (2009) D-amino acids govern stationary phase cell wall remodeling in bacteria. Science 325: 1552-1555.
45. Lewis, K. (2013) Platforms for antibiotic discovery. Nat Rev Drug Discov 12: 371-387.
46. Liechti, G.W., Kuru, E., Hall, E., Kalinda, A., Brun, Y.V., Vannieuwenhze, M., and Maurelli, A.T. (2014) A new metabolic cell-wall labelling method reveals peptidoglycan in Chlamydia trachomatis. Nature 506: 507-510.
47. Livermore, D.M. (2009) Has the era of untreatable infections arrived? J Antimicrob Chemother 64 (Suppl. 1): i29-i36.
48. Longenecker, K.L., Stamper, G.F., Hajduk, P.J., Fry, E.H., Jakob, C.G., Harlan, J.E., etal. (2005) Structure of MurF from Streptococcus pneumoniae co-crystallized with a small molecule inhibitor exhibits interdomain closure. Protein Sci 14: 3039-3047.
49. Lugtenberg, E.J., and v Schijndel-van Dam, A. (1972a) Temperature-sensitive mutants of Escherichia coli K-12 with low activities of the L-alanine adding enzyme and the D-alanyl-D-alanine adding enzyme. J Bacteriol 110: 35-40.
50. Lugtenberg, E.J., and v Schijndel-van Dam, A. (1972b) Temperature-sensitive mutants of Escherichia coli K-12 with low activity of the diaminopimelic acid adding enzyme. J Bacteriol 110: 41-46.
51. Lugtenberg, E.J., and v Schijndel-van Dam, A. (1973) Temperature-sensitive mutant of Escherichia coli K-12 with an impaired D-alanine:D-alanine ligase. J Bacteriol 113: 96-104.
52. Lugtenberg, E.J., De Haas-Menger, L., and Ruyters, W.H. (1972) Murein synthesis and identification of cell wall precursors of temperature-sensitive lysis mutants of Escherichia coli. J Bacteriol 109: 326-335.
53. McCoy, A.J., and Maurelli, A.T. (2005) Characterization of Chlamydia MurC-Ddl, a fusion protein exhibiting D-alanyl-D-alanine ligase activity involved in peptidoglycan synthesis and D-cycloserine sensitivity. Mol Microbiol 57: 41-52.
54. Mengin-Lecreulx, D., Falla, T., Blanot, D., van Heijenoort, J., Adams, D.J., and Chopra, I. (1999) Expression of the Staphylococcus aureus UDP-N-acetylmuramoyl-L-alanyl-D-glutamate:L-lysine ligase in Escherichia coli and effects on peptidoglycan biosynthesis and cell growth. J Bacteriol 181: 5909-5914.
55. Mol, C.D., Brooun, A., Dougan, D.R., Hilgers, M.T., Tari, L.W., Wijnands, R.A., etal. (2003) Crystal structures of active fully assembled substrate- and product-bound complexes of UDP-N-acetylmuramic acid:L-alanine ligase (MurC) from Haemophilus influenzae. J Bacteriol 185: 4152-4162.
56. Munshi, T., Gupta, A., Evangelopoulos, D., Guzman, J.D., Gibbons, S., Keep, N.H., and Bhakta, S. (2013) Characterisation of ATP-dependent Mur ligases involved in the biogenesis of cell wall peptidoglycan in Mycobacterium tuberculosis. PLoS ONE 8: e60143.
57. Nikaido, H. (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67: 593-656.
58. Nosal, F., Masson, A., Legrand, R., Blanot, D., Schoot, B., van Heijenoort, J., and Parquet, C. (1998) Site-directed mutagenesis and chemical modification of the two cysteine residues of the UDP-N-acetylmuramoyl:L-alanine ligase of Escherichia coli. FEBS Lett 426: 309-313.
59. Payne, D.J., Gwynn, M.N., Holmes, D.J., and Pompliano, D.L. (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6: 29-40.
60. Perdih, A., Kotnik, M., Hodoscek, M., and Solmajer, T. (2007) Targeted molecular dynamics simulation studies of binding and conformational changes in E. coli MurD. Proteins 68: 243-254.
61. Perdih, A., Hodoscek, M., and Solmajer, T. (2009a) MurD ligase from E. coli: tetrahedral intermediate formation study by hybrid quantum mechanical/molecular mechanical replica path method. Proteins 74: 744-759.
62. Perdih, A., Kovac, A., Wolber, G., Blanot, D., Gobec, S., and Solmajer, T. (2009b) Discovery of novel benzene 1, 3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach. Bioorg Med Chem Lett 19: 2668-2673.
63. Perdih, A., Hrast, M., Barreteau, H., Gobec, S., Wolber, G., and Solmajer, T. (2014) Benzene-1, 3-dicarboxylic acid 2, 5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF). Bioorg Med Chem 22: 4124-4134.
64. Ruane, K.M., Lloyd, A.J., Fulop, V., Dowson, C.G., Barreteau, H., Boniface, A., etal. (2013) Specificity determinants for lysine incorporation in Staphylococcus aureus peptidoglycan as revealed by the structure of a MurE enzyme ternary complex. J Biol Chem 288: 33439-33448.
65. Sheng, Y., Sun, X., Shen, Y., Bognar, A.L., Baker, E.N., and Smith, C.A. (2000) Structural and functional similarities in the ADP-forming amide bond ligase superfamily: implications for a substrate-induced conformational change in folylpolyglutamate synthetase. J Mol Biol 302: 427-440.
66. Silhavy, T.J., Kahne, D., and Walker, S. (2010) The bacterial cell envelope. Cold Spring Harb Perspect Biol 2: a000414.
67. Silver, L.L. (2003) Novel inhibitors of bacterial cell wall synthesis. Curr Opin Microbiol 6: 431-438.
68. Silver, L.L. (2006) Does the cell wall of bacteria remain a viable source of targets for novel antibiotics? Biochem Pharmacol 71: 996-1005.
69. Silver, L.L. (2011) Challenges of antibacterial discovery. Clin Microbiol Rev 24: 71-109.
70. Silver, L.L. (2013) Viable screening targets related to the bacterial cell wall. Ann N Y Acad Sci 1277: 29-53.
71. Simcic, M., Sosic, I., Hodoscek, M., Barreteau, H., Blanot, D., Gobec, S., and Grdadolnik, S.G. (2012) The binding mode of second-generation sulfonamide inhibitors of MurD: clues for rational design of potent MurD inhibitors. PLoS ONE 7: e52817.
72. Sink, R., Kovac, A., Tomasic, T., Rupnik, V., Boniface, A., Bostock, J., etal. (2008) Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases. ChemMedChem 3: 1362-1370.
73. Skedelj, V., Tomasic, T., Masic, L.P., and Zega, A. (2011) ATP-binding site of bacterial enzymes as a target for antibacterial drug design. J Med Chem 54: 915-929.
74. Smith, C.A. (2006) Structure, function and dynamics in the mur family of bacterial cell wall ligases. J Mol Biol 362: 640-655.
75. Sosic, I., Barreteau, H., Simcic, M., Sink, R., Cesar, J., Zega, A., etal. (2011) Second-generation sulfonamide inhibitors of D-glutamic acid-adding enzyme: activity optimisation with conformationally rigid analogues of D-glutamic acid. Eur J Med Chem 46: 2880-2894.
76. Spraggon, G., Schwarzenbacher, R., Kreusch, A., Lee, C.C., Abdubek, P., Ambing, E., etal. (2004) Crystal structure of an Udp-n-acetylmuramate-alanine ligase MurC (TM0231) from Thermotoga maritima at 2.3 A resolution. Proteins 55: 1078-1081.
77. Strancar, K., Blanot, D., and Gobec, S. (2006) Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD. Bioorg Med Chem Lett 16: 343-348.
78. Strancar, K., Boniface, A., Blanot, D., and Gobec, S. (2007) Phosphinate inhibitors of UDP-N-acetylmuramoyl-L-alanyl-D-glutamate:L-lysine ligase (MurE). Arch Pharm (Weinheim) 340: 127-134.
79. Tanner, M.E., Vaganay, S., van Heijenoort, J., and Blanot, D. (1996) Phosphinate inhibitors of the D-glutamic acid-adding enzyme of peptidoglycan biosynthesis. J Org Chem 61: 1756-1760.
80. Thakur, M., and Chakraborti, P.K. (2008) Ability of PknA, a mycobacterial eukaryotic-type serine/threonine kinase, to transphosphorylate MurD, a ligase involved in the process of peptidoglycan biosynthesis. Biochem J 415: 27-33.
81. Tomasic, T., Zidar, N., Kovac, A., Turk, S., Simcic, M., Blanot, D., etal. (2010) 5-Benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial Mur ligases. ChemMedChem 5: 286-295.
82. Tomasic, T., Kovac, A., Klebe, G., Blanot, D., Gobec, S., Kikelj, D., and Masic, L.P. (2012) Virtual screening for potential inhibitors of bacterial MurC and MurD ligases. J Mol Model 18: 1063-1072.
83. Typas, A., Banzhaf, M., Gross, C.A., and Vollmer, W. (2012) From the regulation of peptidoglycan synthesis to bacterial growth and morphology. Nat Rev Microbiol 10: 123-136.
84. Vollmer, W., Blanot, D., and de Pedro, M.A. (2008) Peptidoglycan structure and architecture. FEMS Microbiol Rev 32: 149-167.
85. Walsh, A.W., Falk, P.J., Thanassi, J., Discotto, L., Pucci, M.J., and Ho, H.T. (1999) Comparison of the D-glutamate-adding enzymes from selected gram-positive and gram-negative bacteria. J Bacteriol 181: 5395-5401.
86. White, C.L., Kitich, A., and Gober, J.W. (2010) Positioning cell wall synthetic complexes by the bacterial morphogenetic proteins MreB and MreD. Mol Microbiol 76: 616-633.
87. Yan, Y., Munshi, S., Leiting, B., Anderson, M.S., Chrzas, J., and Chen, Z. (2000) Crystal structure of Escherichia coli UDPMurNAc-tripeptide d-alanyl-d-alanine-adding enzyme (MurF) at 2.3 A resolution. J Mol Biol 304: 435-445.
88. Zidar, N., Tomasic, T., Sink, R., Kovac, A., Patin, D., Blanot, D., etal. (2011) New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: design, synthesis, crystal structures, and biological evaluation. Eur J Med Chem 46: 5512-5523.
89. Zoeiby, A.E., Beaumont, M., Dubuc, E., Sanschagrin, F., Voyer, N., and Levesque, R.C. (2003) Combinatorial enzymatic assay for the screening of a new class of bacterial cell wall inhibitors. Bioorg Med Chem 11: 1583-1592.